Skip to main content

Illumina Ventures — Portfolio, Page 2

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

52
Companies
$1.4B
Total invested
$27.8M
Avg. check
22
Industries
Biotechnology 22Health Care 12Life Science 10Medical 9Therapeutics 5Genetics 4+16 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 25–48 of 52
Sherlock Biosciences
November 2022

Sherlock Biosciences is an engineering biology company offering unparalleled breadth and versatility for diagnostic solutions.

Biotechnology · CambridgeGrant
SQZ Biotech
March 2022

SQZ Biotech features a cell engineering technology designed to deliver a diverse set of materials into patient cells.

Biotechnology · Watertown$2.0M Grant
Walking Fish Therapeutics
February 2022

Walking Fish Therapeutics is developing a platform to harness B cells’ capability to activate the immune system.

Biotechnology · San Francisco$23.0M Series A
Twist Bioscience
February 2022

Twist Bioscience is a biotechnology company that offers synthetic DNA solutions, gene synthesis, and variant libraries.

B2B · San Francisco$250.0M Post-IPO Equity
CubaseBio
February 2026

Cubase Bio is a biotechnology business that focuses on spatial biology tools.

Biotechnology · Stockholm$4.6M Seed
Alamar Biosciences
January 2026

Powering precision proteomics to enable to the earliest detection of disease.

Biotechnology · Fremont$50.0M Convertible Note
SyntaxBio
December 2025

SyntaxBio develops genetic programming platform that can program cells without the need for consistent external intervention.

Biotechnology · Chicago$856K Grant
Hepta Bio
November 2025

Hepta Bio detect, monitor, and direct the most effective liver treatment.

Biotechnology · San Francisco$6.7M Seed
Predicta Biosciences
October 2025

Predicta Biosciences provides molecular diagnostics and immunotherapeutic discovery services for hematological diseases.

Artificial Intelligence (AI) · Boston$23.4M Series A
NuCicer
July 2025

NuCicer offers high-protein chickpea ingredients with added value in the agri-food system.

Bioinformatics · Davis$11.5M Series A
Broken String Biosciences
July 2025

Broken String Biosciences is developing a platform of novel sequencing tools to assess genome stability and to unlock the next generation.

Biotechnology · CambridgeGrant
Infinity Bio
June 2025

Infinity Bio is a biotech company that offers analytics and insight services for antibody reactome profiling against all human viruses.

Biometrics · Baltimore$8.0M Series A
Arima Genomics
June 2025

Arima Genomics is a biotechnology company that develops solutions to drive genomics discovery.

Biotechnology · San Diego$22.0M Series C
Tagomics
June 2025

Tagomics transforms disease diagnosis through comprehensive multiomic profiling.

Biotechnology · Cambridge$1.2M Grant
Attovia Therapeutics
April 2025

Attovia Therapeutics is a biologics platform specializing in biotherapeutics for immune-mediated diseases.

Biotechnology · San Carlos$90.0M Series C
Biosynch.ai
April 2025

Pioneering the future of medicine through artificial intelligence and computational biology.

San Diego$4.2M Seed
Integrated Biosciences
October 2024

Integrated Biosciences develops next-generation therapeutics.

Biopharma · Redwood City$17.2M Seed
Genome Medical
September 2024

Genome Medical is a telegenomics technology and services company allowing access to genomic-based medicine.

Genetics · South San Francisco$75.3M Series D
Fluent BioSciences
March 2024

Fluent Biosciences, a life science company, offering a molecular analysis of cells without the use of complex microfluidic instrumentation.

Biotechnology · WatertownGrant
Pluton Biosciences
May 2023

Pluton Biosciences tests and discovers microbes for the production of a variety of products, primarily pesticides, and pharmaceuticals.

AgTech · Saint Louis$16.5M Series A
Protillion Biosciences
December 2022

Protillion Biosciences specializes in the design and development of protein-based drugs.

Biopharma · Burlingame$18.0M Series A
LunaPBC
May 2021

LunaPBC is a healthcare company that transforms health data into health breakthroughs.

Biotechnology · San Diego$3.8M Series Unknown
Encoded Therapeutics
March 2021

Encoded Therapeutics is a Harnessing the regulatory genome to create next-generation molecular therapies.

Biotechnology · South San FranciscoSeries D
SerImmune
September 2020

Serimmune is a company that studies immunity to find out how environmental factors affect health and disease.

Biotechnology · Goleta$12.0M Series Unknown

Where Illumina Ventures invests

Biotechnology22
Health Care12
Life Science10
Medical9
Therapeutics5
Genetics4

About Illumina Ventures's portfolio

How many companies has Illumina Ventures invested in?▸

Illumina Ventures has invested in 52 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Illumina Ventures invest in?▸

Illumina Ventures's top investment sectors include Biotechnology, Health Care, Life Science, Medical, Therapeutics. The firm invests across 22 different industry categories.

What is Illumina Ventures's largest investment?▸

Among tracked funding rounds, Twist Bioscience received $250.0M in a Post-IPO Equity round. Illumina Ventures's total known invested capital is $1.4B.

What is the average investment size for Illumina Ventures?▸

Illumina Ventures's average investment size is $27.8M across its portfolio of 52 companies.

What are Illumina Ventures's most recent investments?▸

Recent Illumina Ventures portfolio additions include Sherlock Biosciences, SQZ Biotech, Walking Fish Therapeutics, Twist Bioscience, CubaseBio. These companies were founded in 2020 or later.

Reach the founders behind these 52 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →